Stocks
Nanobiotix S.A.NBTX
NASDAQHealthcareBiotechnology$29.36
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing radioenhancers, primarily its lead candidate NBTXR3, which is being evaluated in head and neck cancer and other solid tumors. The company has a global partnership with LianBio for development in Greater China and is listed on both Euronext Paris and Nasdaq. Investors track it for its novel mechanism of action and upcoming clinical data readouts.
52W Range: $14.78-$57.14
Congressional Interest in Nanobiotix S.A. (NBTX)
No congressional trades have been disclosed for Nanobiotix S.A. (NBTX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading NBTX?
No congressional trades found for this stock.